Overview

Update
Total Equity Funding
$47.3M in 4 Rounds from 10 Investors
Most Recent Funding
$11.8M Series B on July 9, 2015
Headquarters:
Toronto, ON
Description:
Xagenic is a molecular diagnostics company developing on-demand molecular testing, facilitating faster treatment decisions for patients.
Founders:
Categories:
Medical Device, Biotechnology, Health Diagnostics
Website:
http://www.xagenic.com
Social:

Company Details

Update
Founded:
2010
Contact:
416-363-1999
Employees:
11 - 50 | 4 in Crunchbase

Xagenic Inc., a Toronto, Canada-based molecular diagnostics company developing a new technology for decentralized, rapid diagnostic testing and a true point-of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs. Xagenic has adapted this technology to permit rapid, enzyme-free detection of nucleic acids from clinical samples.

We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.

Funding Rounds (4) - $47.3M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jul, 2015$15M / Series B4
Jul, 2014$25.5M / Series B5
Jan, 2012$10M / Series A4
Feb, 2011undisclosed amount / Seed1

Current Team (4)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Headquarters

    55 York Street

    Suite 1000

    Toronto, ON M5J 1R7

    CAN

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos